As a well-recognized CSC marker in PC and other cancers, CD44+ PC cells displayed significantly enhanced tumorigenicity and metastasis compared with CD44- cells [19], and small numbers of CD44+/CD24- initiated tumors in a xenograft model [20]. Here, CD44 is linked to pachyonychia congenita.